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Matthew P Longnecker7, Ruthann A Rudel8, Susan L Teitelbaum3, Robin M Whyatt9 and Mary S Wolff3*
See related research by Sprague et al., http://breast-cancer-research.com/content/15/3/R45We noted serious methodologic issues in the measure-
ment of bisphenol A (BPA), phthalate diesters, and their
metabolites in blood serum and other tissues, as
reported in the recent Breast Cancer Research article by
Sprague and colleagues [1]. Such measurements are ana-
lytically possible. However, for the reasons that follow, it
is seldom possible to verify that serum concentrations of
these compounds are valid measures of exposure.
BPA and phthalate diesters are non-persistent in the
body; they metabolize quickly and, as a result, the levels of
their polar, hydrophilic metabolites in blood can be several
orders of magnitude lower than in urine (controlled hu-
man studies suggest 30- to 100-fold higher levels in urine
than serum) [2-4]. Such low levels increase the possibility
that contamination can obscure true exposures.
Extraneous sources of phthalate diesters include plastics,
personal care and consumer products, and building fur-
nishings [2,5]. Phthalate diesters derived externally can
easily contaminate blood serum and other human matri-
ces and overwhelm the very low levels in blood from daily
exposures [2,4]. Hydrolytic enzymes are ubiquitous in
blood and most other matrices (but not urine). These en-
zymes rapidly hydrolyze extraneous phthalate diesters to* Correspondence: mary.wolff@mssm.edu
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We thank Calafat and colleagues for their discussion of
BPA and phthalate measurement. Their comments on the
challenges of exposure assessment for rapidly metabolized
chemicals echo the statements in our discussion. They
© BioMed Central Ltd.2013their corresponding monoesters, beginning immediately
after sample collection, and this can artificially elevate the
concentrations of these hydrolytic monoesters, including
monoethyl phthalate and mono-(2-ethylhexyl) phthalate.
To the best of our knowledge, phthalate oxidative metabo-
lites (such as mono-(2-ethyl-5-oxohexyl) phthalate) do not
form as a result of recent external contamination. The oxi-
dative metabolites were not measured in the study by
Sprague and colleagues [1]. Therefore, in blood, saliva, or
tissues other than urine, only the phthalate oxidative me-
tabolites (not the phthalate diesters or the hydrolytic
monoesters) are valid exposure biomarkers.
BPA also has extraneous sources such as plastics [3,5].
There are currently no comparable oxidative metabolites
that can exclude recent contamination, but conjugated
BPA (not ‘free’ BPA) is the most valid exposure biomarker
and is not present to any significant degree in biological
samples other than urine. For these reasons, urine is the
best matrix for epidemiological assessment of exposure to
BPA, phthalates, and other polar, non-persistent chemicals
to whose exposures can be episodic in nature.
Moreover, because both BPA and the phthalate diesters
have very short half-lives (regardless of the biomarker used),g, Jocelyn DC Hemming, John M Hampton, Diana SM Buist,
further emphasize the susceptibility of blood serum mea-
sures to contamination. We took several rigorous steps to
avoid plasticizer contamination, including the use of glass
labware, preparation steps to remove potential contami-
nants from labware, handling of labware and specimens in
biosafety cabinets, and the assessment of method blanks
as recommended in the literature [6]. Assessment of
method blanks showed that iatrogenic contamination was
lower than the limits of detection for BPA and phthalates.
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resent the daily habits of research subjects versus brief expo-
sures from iatrogenic sources, such as collection devices,
clinical apparatus, and tubing from medical procedures [2,5].
Non-differential measurement error due to contamin-
ation would tend to attenuate the observed associations
between the measured chemicals and mammographic
breast density. However, for contamination to explain
the observed positive associations of BPA and monoethyl
phthalate with breast density, the samples from patients
with high breast density would need to be more greatly
contaminated. The conditions for introducing a positive
bias by sample contamination are not readily apparent.
Nevertheless, we agree that accurate biomarker assess-
ment is essential for elucidating the role of environmen-
tal chemicals in the etiology of breast cancer. Future
studies that measure metabolites less susceptible to con-
tamination, use a variety of specimen types (including
urine), and assess exposure levels at multiple points in
time are needed.
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